Introduction
Infectious diseases have always been serious health problems with high morbidity and mortality in humans. Even though pharmaceutical companies have produced a number of new antibiotics in the past decade, resistance to these drugs has increased and has now become a global concern [1] . The global emergence of multi-drug resistant bacteria is increasingly limiting the effectiveness of current drugs and significantly causing treatment failure [2] . Staphylococcus aureus ( S. aureus) is one of the most important human pathogens associated with hospital and communityacquired infections. Over the decades, the number and proportion of drug resistant pathogens, including methicillin-resistant S. aureus (MRSA), vancomycinresistant Enterococci, cephalosporin-resistant Klebsiella pneumonia, fluoroquinolone-resistant Pseudomonas aeruginosa, multi-drug resistant Gram-negative bacteria and extensively drug resistant tuberculosis infections in different countries have increased due to the rise of epidemics in humans [3] [4] [5] . Consequently, new and innovative antimicrobial agents are urgently needed to combat these life threatening infections.
New trends in drug discovery from natural sources emphasize investigation on the marine ecosystem to explore numerous complex and novel chemical entities [6] . It is noteworthy that marine sources have also demonstrated tremendous abilities as producers of anticancer compounds and bioactive secondary metabolites which act against infectious diseases and inflammation [7] . Among the marine organisms, microbial-derived natural products are playing a significant role in the drug discovery process [8] . Marine Actinobacteria represent a rich source of new molecules with pharmacological properties, which are lead compounds for the development of new drugs [9, 10] . Recently, spongederived actinomycetes have been attracting increasingly interests as potential sources of unique and unusual bioactive secondary metabolites [11] . The isolation of secondary metabolite-producing bacteria from sponges and of microbial secondary metabolism gene clusters from the metagenome of sponges has led to the general understanding that these metabolites are, in many cases, the products of microbial symbionts and are not derived from the microbial diet of sponges [12] . In continuation of our studies on sponge-derived actinomycetes we now report on the bioactive compound against multi-drug resistant pathogens produced by Salinispora sp. isolated from the marine sponge Theonella sp. The goal of the present study is to isolate a bioactive compound showing antibacterial activities from the strain of Salinispora sp. FS-0034, which was isolated from the Fijian marine invertebrate.
Materials and methods

General experimental procedures
The ultraviolet (U V) spectrum was acquired in spectroscopy grade methanol using a PerkinElmer Lambda 3 5 spectrophotometer. Nuclear 
Sample collection and processing
The sponge Theonella sp. was collected by hand using selfcontained underwater breathing apparatus at a depth of 10 The sponge sample was rinsed three times with sterile seawater to eliminate nonspecific microbial propagules that stick to the sponge surface from the seawater, and the surface of the sponge tissue was subjected to surface-sterilization by using 70% ethanol under aseptic conditions. The surface sterilized sponge tissue was then cut into small pieces of approximately 0.1 cm 3 , homogenized and diluted with autoclaved membranefiltered seawater. The resulting homogenate was diluted with sterile seawater at three dilutions (1:10, 1:100, and 1:1 000). Hundred microliters of each dilution was plated onto A1 agar (10 g of starch, 4 g of yeast extract, 2 g of peptone, 18 g of agar and 1 L of filtered natural seawater) medium. The isolation medium was amended with cycloheximide (100 µg/mL) and polymixin B (5 µg/mL) after autoclaving to avoid unwanted Gram negative bacteria and fungi contamination. The plates were incubated at 28 °C for [3] [4] weeks until the morphology of actinomycetes could be distinguished.
Isolation of Salinispora strains
Actinomycetes were evaluated on each plate by eye and with the aid of an Olympus SZ51 binocular zoom stereomicroscope (8-40伊) . Actinomycetes were recognized by the presence of filamentous hyphae, a characteristic that was just within the range of detection at the highest magnification used, and/or by the formation of tough, leathery colonies that adhered to the agar surface. Colonies were assigned to the genera Salinispora if, for larger colonies, they produced orange pigment, black spores that darkened the colony surface, and lacked areal hyphae. Smaller colonies, viewed microscopically, could be ascribed to the Salinispora group if they possessed finely branched, scattered hyphae that formed a moderately developed substrate mycelium as described by Jensen, et al [13] . Salinispora-like colonies were successively transferred onto new media until pure cultures were obtained. All pure strains were grown in liquid culture and cryopreserved at -80 °C in 10% glycerol.
Seawater requirement test
The Salinispora strains were reported as the first o b l i g a t o r y m a r i n e a c t i n o m y c e t e s w h i c h n e e d e d seawater for their growth [13, 14] . Thus, all of the isolated Salinispora-like actinomycetes were tested for the requirement of seawater for growth. Fresh Salinisporalike actinomycetes' colonies were streaked on A1 agar plate prepared with seawater and a plate prepared with filtered distilled water. Growth was monitored on both plates visually and with the aid of a stereomicroscope for up to 4 weeks. If no growth was observed on the plate prepared with filtered distilled water, that strain was determined to require seawater for growth.
Bioassay and selection of potential strain
All the isolated Salinispora strains were subjected for small scale fermentation by inoculating each strain in 100 mL A1B medium (1 g of starch, 0.4 g of yeast extract, 0.2 g of peptone) incubating at 28 °C in temperature controlled incubator at 200 r/min for 7-14 d. After incubation, the whole cultures (100 mL) were extracted twice with equal volumes of ethyl acetate (EtOAc) using a separating funnel. The EtOAc crude extract was dried in vacuo using rotary evaporator under 35 °C . Each crude extract of the strains was tested for bioassay against methicillin-resistant Staphylococcus aureus (S. aureus) (MRSA), wild type S. aureus (WTSA), vancomycin-resistant Enterococcus faecium (E. faecium) (VREF), amphotericin resistant Candida albicans (C. albicans) and wild type C. albicans at 250 µg/disc concentration. The highest bioactivity displayed strain was selected for mass production in order to produce enough metabolites for purification of bioactive compounds.
Extraction and isolation
Salinispora sp. FS-0034 was cultured in 24 Fernbach flasks (2.8 L) each containing 1 L of a natural seawaterbased A1B medium. The whole culture broth along with cells was extracted twice with EtOAc by sonication for [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] min. The EtOAc phase was concentrated in vacuo to give a crude extract (2.77 g). The crude EtOAc extract was subjected to normal phase vacuum liquid chromatography with mixtures of direct-current main and MeOH in gradually increasing the polarity. A total of eleven fractions were obtained which were subjected to bioassay. All the fractions showed activity against MRSA, WTSA and VREF. However, fraction three (FS-0034F3) was selected for further purification based on higher bioactivity and quantity. FS-0034F3 was subjected to RP C 18 column chromatography using mixtures of MeOH/H 2 O.
A total of sixteen fractions were collected and pooled to three fractions (FS-0034F3F1 to FS-0034F3F3) based on the profiles on TLC. Fraction FS-0034F3F1 was further selected for purification by RP 
Antibacterial assay
The minimum inhibitory concentrations (MICs) of compound 1 against different test organisms were determined by the broth dilution method [15] . The 
Results
A t o t a l o f e i g h t e e n Salinispora s t r a i n s w e r e isolated from the sponge tissues of Theonella sp. The characteristics of obligatory growth in seawater based medium and colony morphology confirmed the isolates as Salinispora spp. Further all the Salinispora strains were subjected for bioassay against drug-resistant pathogens. All the eighteen strains displayed activity against MRSA and WTSA with fourteen strains active against VREF. The strain FS-0034 exhibited highest antibacterial activity against multi-drug resistant human pathogens (Table 2) . H-28 showed COSY to H-34a. The COSY spectrum also displayed other methine-methyl and methinemethine correlations as given in Figure 3 . In addition, the carbon values were tentatively assigned by comparison to the literature [16] . Supportively, HMBC correlations ( Figure  4 ) confirm the correct assignments of the methyls and the aromatic proton, further affirming the proposed structure for compound 1 
Discussion
N ovel A ctinobacteria with biopharmaceutical potential have been increasingly isolated from marine habitats [10, 14, 17] . The Salinispora group, as a relatively newly discovered group of Actinobacteria have been found in diverse habitats such as marine sediments and marine sponges [14, 17, 18] . The marine actinomycete genus Salinispora is composed of three closely related species (Salinispora arenicola, Salinispora pacifica and Salinispora tropica) that have been identified so far [19] . These bacteria have proven to be a rich source of secondary metabolites, which are produced in speciesspecific patterns that include antibacterial, potent cytostatic, anticancer, antimalarial and proteasome inhibitor activities [9, 10] . In the present study, eighteen strains were isolated and confirmed as Salinispora strains due to its stringent requirement of seawater for growth and other morphological characteristics [13, 14] . All isolated strains in the present study showed significant antibacterial activity against multi-drug resistant pathogens. Among them, a highest bioactivity showing Salinispora sp. FS-0034 was subjected to production and purification of bioactive compounds yielding the strong MRSA and VREF active rifamycin W.
Rifamycins, a group of antibiotics of the ansamycin family [20] , are clinically important antibacterial agents active against Gram-positive bacteria. Several semisynthetic rifamycin variants (e.g., rifampin) have been used clinically for the treatment of tuberculosis and other bacterial infections, but resistance threatens their effectiveness [21] . Rifamycins are known to be produced by the soil actinobacterial species Amycolatopsis mediterranei and Nocardia mediterranei and rifamycin synthesis has been most intensively studied in these species [22, 23] . The gene cluster for the biosynthesis of rifamycin B, a compound forming the basis for all other rifamycins, has been characterized only in Amycolatopsis mediterranei [22, 23] . However it has recently been reported that members of marine genus Salinispora are known to produce compounds of the rifamycin class, including rifamycin B and rifamycin SV [18, 24] . In the present study we reported rifamycin W from the Salinispora sp. FS-0034. Rifamycin W was previously isolated from the fermentation medium of the mutant strain Nocardia mediterranei [16] . Therefore, the marine obligate Salinispora group of actinobacteria represents a potential new source of rifamycins outside the soil genera Amycolatopsis and Nocardia. Further, the present study has added strength to the biological properties of rifamycin W as it was showed strong antibacterial activity against multi-drug resistant human pathogens. Herein we report the isolation of rifamycin W from a sponge-associated Salinispora sp. and describe its strong antibacterial activity against multi-drug resistant human pathogens including MRSA, WTSA and VREF. The consistent production of specific classes of secondary metabolites by Salinispora species will raise the expectancy in this group to discover novel drug leads.
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Comments
Background
The increasing emergence of multi-drug resistant human pathogens is seriously limiting the effectiveness of currently available drugs and significantly causing treatment failure. The ocean is an important source of bioactive substances and numerous antibiotics derived from the marine play a significant role in the treatment of many diseases. The search for new and innovative antimicrobial agents has become an urgent issue facing humanity.
Research frontiers
In the present study, the authors isolated a bioactive compound, rifamycin W, from sponge-associated Salinispora sp. using various spectrum analysis methods and examined its appreciable antibacterial activity against multi-drug resistant human pathogens by MIC assays.
Related reports
This study also provided the specific information about the rifamycin W, including the molecular formula and the molecular structure using various spectral analysis of UV, HRESIMS, 1 H NMR, COSY and HMBC spectral data.
Innovations and breakthroughs
Recently members of marine genus Salinispora are reported to produce compounds of the rifamycin class, including rifamycin B and rifamycin SV. In the present study, the authors isolated rifamycin W from the Salinispora sp. with strong antibacterial activity, showing that the marine obligate Salinispora group of actinobacteria can represent a potential new source of rifamycins.
Applications
The research work illustrated the strong antibacterial activity of rifamycin W (compound 1) against multi-drug resistant human pathogens, indicating that secondary metabolites from Salinispora species have potential to be developed as novel antibacterial agents.
Peer review
This is a good research paper in which the authors obtained rifamycin W (compound 1) from the EtOAc extract of the culture of Salinispora sp. FS-0034 and found that it had potent antibacterial activity. The results are meaningful and valuable and lay a solid foundation for further studies.
